Enhabit (NYSE:EHAB) Releases FY 2025 Earnings Guidance

Enhabit (NYSE:EHAB - Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 0.410-0.510 for the period, compared to the consensus EPS estimate of 0.290. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Enhabit Stock Up 6.3 %

NYSE:EHAB traded up $0.51 during trading hours on Friday, reaching $8.53. 487,962 shares of the company traded hands, compared to its average volume of 296,526. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The business's 50-day moving average price is $8.20 and its two-hundred day moving average price is $7.91. Enhabit has a 1 year low of $6.85 and a 1 year high of $11.74. The stock has a market capitalization of $428.67 million, a P/E ratio of -3.67 and a beta of 1.80.

Analysts Set New Price Targets

EHAB has been the topic of a number of analyst reports. Leerink Partners reiterated a "market perform" rating and issued a $8.00 price target (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. Jefferies Financial Group raised shares of Enhabit from a "hold" rating to a "buy" rating and lifted their target price for the stock from $8.25 to $9.50 in a report on Monday, December 9th.

Insiders Place Their Bets

In related news, Director Jeffrey Bolton purchased 4,000 shares of the company's stock in a transaction dated Thursday, December 12th. The shares were purchased at an average price of $8.69 per share, with a total value of $34,760.00. Following the acquisition, the director now directly owns 98,144 shares in the company, valued at $852,871.36. The trade was a 4.25 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stuart M. Mcguigan purchased 15,000 shares of Enhabit stock in a transaction dated Tuesday, December 10th. The stock was bought at an average price of $8.81 per share, with a total value of $132,150.00. Following the completion of the purchase, the director now directly owns 46,810 shares of the company's stock, valued at approximately $412,396.10. This trade represents a 47.15 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.90% of the company's stock.

Remove Ads

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.